We demonstrate a DNAzyme-based walker system as a controlled oligonucleotide drug AS1411 release platform for breast cancer treatment. In this system, AS1411 strands are released from fuel strands as a walker moves along its carbon nanotube track. The release rate and amount of anticancer oligonucleotides are controlled by the walker operation. With a walker system embedded within the collagen extracellular matrix, we show that this drug release system can be used for in situ cancer cell growth inhibition.
Keywords: DNA walker; DNAzyme; anticancer; growth inhibition; oligonucleotides.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.